Oroxin A alleviates early brain injury after subarachnoid hemorrhage by regulating ferroptosis and neuroinflammation

Junhui Chen,Zhonghua Shi,Chunlei Zhang,Kun Xiong,Wei Zhao,Yuhai Wang

DOI: https://doi.org/10.1186/s12974-024-03099-3

IF: 9.3

2024-05-06

Journal of Neuroinflammation

Abstract:Subarachnoid hemorrhage (SAH), a severe subtype of stroke, is characterized by notably high mortality and morbidity, largely due to the lack of effective therapeutic options. Although the neuroprotective potential of PPARg and Nrf2 has been recognized, investigative efforts into oroxin A (OA), remain limited in preclinical studies.

immunology,neurosciences

What problem does this paper attempt to address?

### Problems Addressed by the Paper

The paper primarily explores the following issues:

1. **Treatment of Subarachnoid Hemorrhage (SAH)**:
- Subarachnoid hemorrhage is a severe subtype of stroke with high mortality and disability rates. Although there are some studies on the neuroprotective potential of PPARγ and Nrf2, the application of oroxin A (OA) in preclinical research remains limited.

2. **Mechanisms of Early Brain Injury (EBI)**:
- The study aims to investigate the effects of OA on early brain injury caused by SAH and improve neurological function by regulating ferroptosis and neuroinflammation. Specifically, the research found that OA significantly increased survival rates, improved neurological function, reduced neuronal death and brain edema, and attenuated inflammatory responses.

3. **Regulatory Mechanisms of Ferroptosis**:
- Further mechanistic studies indicate that OA promotes the translocation of nuclear factor erythroid 2-related factor 2 (Nrf2) from the cytoplasm to the nucleus, thereby activating the Nrf2/GPX4 pathway. Additionally, OA upregulated the expression of FSP1, suggesting its important protective role in synergizing with GPX4 to combat early brain injury following SAH.

In summary, this paper explores the neuroprotective effects of OA in an SAH model and its potential mechanisms through a series of experiments, particularly by inhibiting ferroptosis. These findings may provide new insights for future drug development and clinical treatment.